FMP
Isoray, Inc.
ISR
AMEX
Inactive Equity
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
0.384 USD
0 (0%)
About
ceo
Ms. Lori A. Holmes-Woods
sector
Healthcare
industry
Medical - Devices
website
https://isoray.comexchange
AMEX
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
CIK
0000728387
ISIN
US46489V1044
CUSIP
46489V104
Address
350 Hills Street
Phone
509 375 1202
Country
US
Employee
66
IPO Date
May 31, 2002
Key Executives
